Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation

Transplantation

Volumn 94, Issue 6, 2012, Pages 646-651

  Dowsley, Taylor F ^a   Bayne, David B ^a   Langnas, Alan N ^a   Dumitru, Ioana ^a   Windle, John R ^a   Porter, Thomas R ^a   Raichlin, Eugenia ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

and Diastolic dysfunction; Cirrhotic cardiomyopathy; Heart failure

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GRAFT SURVIVAL; HEART FAILURE; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MITRAL VALVE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; THORAX RADIOGRAPHY; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; ARTERIAL PRESSURE; CASE-CONTROL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MITRAL VALVE; MULTIVARIATE ANALYSIS; NEBRASKA; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84866731415     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825f0f97     Document Type: Article

References (32)

1. Rayes N, Bechstein WO, Keck H, et al. Changing patterns of causes of death after liver transplantation: an analysis of 41 cases in 382 patients. Transplant Proc 1995; 27: 123-7.
2. Dec GW, Kondo N, Farrell ML, et al. Cardiovascular complications following liver transplantation. Clin Transplant 1995; 9: 46-3.
3. Raval Z, Harinstein ME, Skaro AI, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 50: 22-3.
4. Zardi EM, Abbate A, Zardi DM, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010; 56: 53-9.
5. Ripoll C, Yotti R, Bermejo J, et al. The heart in liver transplantation. J Hepatol 2011; 54: 81-0.
6. Kowalski HJ AW. The cardiac output at rest in Laennec cirrhosis. J Clin Invest 1953; 32: 102-5.
7. Henriksen JH, Fuglsang S, Bendtsen F, et al. Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis. Ugeskr Laeger 2004; 166: 299-5.
8. Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010; 53: 17-9.
9. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 113-1.
10. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996; 25: 13-5.
11. Ripoll C, Catalina MV, Yotti R, et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008; 85: 176-6.
12. Myers RP, Lee SS. Cirrhotic cardiomyopathy and liver transplantation. Liver Transpl 2000; (4 suppl 1): S4-4.
13. Valeriano V, Funaro S, Lionetti R, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95: 320-0.
14. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 128-4.
15. Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005; 45: 8-7.
16. Yturralde RF, GaaschWH. Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis 2005; 47: 31-4.
17. Lunseth JH, Olmstead EG, Abboud F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. Arch Intern Med 1958; 102: 40-5.
18. Inserte J, Perello A, Agullo L, et al. Left ventricular hypertrophy in rats with biliary cirrhosis. Hepatology 2003; 38: 58-9.
19. Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Postgrad Med J 2009; 85: 4-4.
20. Eimer MJ, Wright JM, Wang EC, et al. Frequency and significance of acute heart failure following liver transplantation. Am J Cardiol 2008; 101: 24-2.
21. Limas CJ, Guiha NH, Lekagul O, et al. Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. Circulation 1974; 49: 75-4.
22. Caramelo C, Fernandez-Munoz D, Santos JC, et al. Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats. Hepatology 1986; 6: 12-9.
23. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363: 146-1.
24. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 2000; 6: 45-3.
25. Day CP, James OF, Butler TJ, et al. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet 1993; 341: 142-3.
26. Lazzeri C, La Villa G, Laffi G, et al. Autonomic regulation of heart rate and QT interval in nonalcoholic cirrhosis with ascites. Digestion 1997; 58: 58-0.
27. Mohamed R, Forsey PR, Davies MK, et al. Effect of liver transplantation on QTinterval prolongation and autonomic dysfunction in endstage liver disease. Hepatology 1996; 23: 112-8.
28. Garcia Gonzalez M, Hernandez-Madrid A, Lopez-Sanroman A, et al. Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. Transplant Proc 1999; 31: 236-6.
29. Henriksen JH, Bendtsen F, Hansen EF, et al. Acute non-selective betaadrenergic blockade reduces prolonged frequency-Adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol 2004; 40: 23-9.
30. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 7-9.
31. de Simone G, Daniels SR, Kimball TR, et al. Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension 2005; 45: 6-4.
32. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 155-0.